ReachMD

Be part of the knowledge.™

Popular

- Michael E. Thase, MD
  Peer
- Sagar V. Parikh, MD
  Peer
0
CME/CE
The Evolving Role of Rapid-Acting Agents for the Treatment of MDD
The Evolving Role of Rapid-Acting Agents for the Treatment of MDD
0.25 credits
- Anita H. Clayton, MD
  Peer
- Nancy Byatt, DO
  Peer
- Jennifer L. Payne, MD
  Peer
2
CME/CE
Perspectives on New Directions in the Management of Postpartum Depression
Perspectives on New Directions in the Management of Postpartum Depression
0.25 credits
- Michael Miller, MD, FACC, FAHA, FNLA
  Peer
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Aruna Pradhan, MD, MPH
  Peer
- James A. Underberg, MD
  Peer
2
CME/CE Meeting
Adopting the New Therapeutic “LineUp” to Manage ASCVD - East
Sarasota, Florida
February 04, 2022
07:45 AM - 12:00 PM EST
3.50 creditsLearn more
- Mark Socinski, MD
  Peer
- John V. Heymach, MD, PhD
  Peer
1
CME/CE
Keeping Pace in Lung Cancer – How Would You Treat? Case-Based Learning in EGFR-Mutant NSCLC
Keeping Pace in Lung Cancer – How Would You Treat? Case-Based Learning in EGFR-Mutant NSCLC
0.25 credits
- Mark Socinski, MD
  Peer
- Benjamin Levy, MD
  Peer
0
CME/CE
Keeping Pace in Lung Cancer: Clinical Case Challenges in NSCLC
Keeping Pace in Lung Cancer: Clinical Case Challenges in NSCLC
0.25 credits
- Mark Socinski, MD
  Peer
- Edward B. Garon, MD, MS
  Peer
2
CME/CE
Keeping Pace in Lung Cancer – All About Antiangiogenics and TKIs: Current Roles and Future Directions in EGFR-Mutant NSCLC
Keeping Pace in Lung Cancer – All About Antiangiogenics and TKIs: Current Roles and Future Directions in EGFR-Mutant NSCLC
0.25 credits
- Peter Rossing, DMSc, MD
  Peer
- Gerasimos S. Filippatos, MD, FESC, FHFA, FHFSA(h)
  Peer
- Matthew R. Weir, MD
  Peer
0
CME/CE
New Insights into the Management of CKD in T2D: The Role of MRA Therapies
New Insights into the Management of CKD in T2D: The Role of MRA Therapies
0.25 credits
- Mark Socinski, MD
  Peer
- Edward B. Garon, MD, MS
  Peer
0
CME/CE
Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunotherapy in NSCLC
Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunotherapy in NSCLC
0.25 credits
- William Mencia, MD, FACEHP, CHCP
  Peer
- Eliza B. Geer, MD
  Peer
0
CME/CE
Normalizing mUFC in Cushing’s Disease
Normalizing mUFC in Cushing’s Disease
0.25 credits
- Murray Epstein, MD
  Peer
- Gates B. Colbert, MD, FASN
  Peer
0
CME/CE
Considerations When Using a Potassium Binder in Patients with CKD
Considerations When Using a Potassium Binder in Patients with CKD
0.25 credits
- Anita H. Clayton, MD
  Peer
3
CME/CE Broadcast Replay
Advances in Postpartum Depression: What You Need to Know
Advances in Postpartum Depression: What You Need to Know
0.50 credits
- Clete A. Kushida, MD, PhD
  Peer
- Lois E. Krahn, MD
  Peer
4
CME/CE
Update on Treatment Options for Narcolepsy
Update on Treatment Options for Narcolepsy
0.25 credits
- Mark Socinski, MD
  Peer
- Justin Gainor, MD
  Peer
1
CME/CE
Keeping Pace in Lung Cancer: Applying the Right Therapy to the Right Patient in RET-Positive NSCLC
Keeping Pace in Lung Cancer: Applying the Right Therapy to the Right Patient in RET-Positive NSCLC
0.25 credits
- Lee P. Shulman, MD, FACMG, FACOG
  Peer
- Erica E. Marsh MD, MSCI, FACOG
  Peer
7
CME/CE
Factors That Delay Diagnosis of Uterine Fibroids and Endometriosis: The Demographic Divide
Factors That Delay Diagnosis of Uterine Fibroids and Endometriosis: The Demographic Divide
0.25 credits
- Michael Miller, MD, FACC, FAHA, FNLA
  Peer
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Aruna Pradhan, MD, MPH
  Peer
- James A. Underberg, MD
  Peer
1
CME/CE Live Broadcast
Adopting the New Therapeutic “LineUp” to Manage ASCVD - East
Adopting the New Therapeutic “LineUp” to Manage ASCVD - East
East Coast
February 04, 2022
08:30 AM - 12:00 PM EST
3.50 creditsLearn more

Clinical Practice

Segment Chapters

Playlist:

Recommended

Webpack App